Cargando…
Overexpression of p62/IMP2 can Promote Cell Migration in Hepatocellular Carcinoma via Activation of the Wnt/β-Catenin Pathway
p62/IMP2 is an oncofetal protein that was first reported as a tumor-associated antigen in hepatocellular carcinoma (HCC). In our previous studies, we demonstrated a high frequency of p62/IMP2 autoantibodies appearing in various types of cancer. Therefore, we hypothesize that p62/IMP2 plays an import...
Autores principales: | Xing, Mengtao, Li, Pei, Wang, Xiao, Li, Jitian, Shi, Jianxiang, Qin, Jiejie, Zhang, Xiaojun, Ma, Yangcheng, Francia, Giulio, Zhang, Jian-Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7017416/ https://www.ncbi.nlm.nih.gov/pubmed/31861402 http://dx.doi.org/10.3390/cancers12010007 |
Ejemplares similares
-
p62/IMP2 stimulates cell migration and reduces cell adhesion in breast cancer
por: Li, Yang, et al.
Publicado: (2015) -
IMP2/p62 induces genomic instability and an aggressive hepatocellular carcinoma phenotype
por: Kessler, S M, et al.
Publicado: (2015) -
WNT7A Overexpression Inhibits Growth and Migration of Hepatocellular Carcinoma via the β-Catenin Independent Pathway
por: Lan, Lihui, et al.
Publicado: (2019) -
Humoral Autoimmune Responses to Insulin-Like Growth Factor II mRNA-Binding Proteins IMP1 and p62/IMP2 in Ovarian Cancer
por: Liu, Xinxin, et al.
Publicado: (2014) -
Dysregulation of Wnt/β‐catenin signaling by protein kinases in hepatocellular carcinoma and its therapeutic application
por: Li, Qian, et al.
Publicado: (2021)